Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., Aug. 5, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

Additional Resources:

Media Contact: Lee.Herring@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)


SOURCE U.S. Food and Drug Administration

These press releases may also interest you

at 16:55
Pfizer Inc. announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic...

at 16:54
Chubb has appointed Robert Poliseno Chief Operating Officer, North America Field Operations. Mr. Poliseno succeeds Jeffrey Updyke, who has been named head of Chubb's North America Small Business segment.  ...

at 16:40
Aware, Inc. , a leading global provider of biometrics software products, solutions and services, has appointed Gateway Investor Relations, a leading strategic financial communications and capital markets advisory firm, to build and deploy a new...

at 16:40
Chubb announced that it has named Jeffrey Updyke Vice President, Chubb Group and Division President, Chubb Small Business. In this capacity, Mr. Updyke will have executive operating responsibility for Chubb's retail insurance business that serves...

at 16:35
Legend Biotech Corporation (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate in the Jefferies Virtual Cell...

at 16:35
Shape Therapeutics, Inc. (ShapeTX), a pre-clinical stage company with an industry-leading RNA targeting technology platform, announced today that Francois Vigneault, PhD., President & Chief Executive Officer, will highlight advances in their RNAfixtm...

News published on 5 august 2020 at 18:05 and distributed by: